Small interfering RNA targeting toll-like receptor 9 protects mice against polymicrobial septic acute kidney injury

Nephron - Experimental Nephrology

Volumn 122, Issue 1-2, 2013, Pages 51-61

  Liu, Lixia ^a   Li, Yong ^a   Hu, Zhenjie ^a   Su, Jie ^a   Huo, Yan ^a   Tan, Bibo ^a   Wang, Xiaoling ^a   Liu, Yueping ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; Apoptosis; Sepsis; Small interfering RNA; Toll like receptor

Indexed keywords

CREATININE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 9;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CECAL LIGATION AND PUNCTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; GENE EXPRESSION; HISTOPATHOLOGY; HYDRODYNAMICS; KIDNEY CELL; KIDNEY PARENCHYMA; LIGATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMICROBIAL SEPTIC ACUTE KIDNEY INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCTURE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESUSCITATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY; MALE; MICE; MICE, INBRED CBA; RNA, SMALL INTERFERING; SEPSIS; TOLL-LIKE RECEPTOR 9;

EID: 84875672871     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000346953     Document Type: Article

References (48)

1. Lafrance JP, Miller DR: Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 2010; 21: 345-352.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818.
3. Silvester W, Bellomo R, Cole L: Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29: 1910-1915.
4. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
5. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
6. Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388: 621-625.
7. Anders HJ: Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010; 21: 1270-1274.
8. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-397.
9. O'Neill LA: The interleukin-1 receptor/Tolllike receptor superfamily: 10 years of progress. Immunol Rev 2008; 226: 10-18.
10. El-Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, Dagher PC: Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 2006; 290:F1034-F1043.
11. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ: Role of Toll-like receptor-4 in endotoxin-induced acute renal failure. J Immunol 2004; 172: 2629-2635.
12. Weighardt H, Kaiser-Moore S, Vabulas RM, Kirschning CJ, Wagner H, Holzmann B: Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol 2002; 169: 2823-2827.
13. Dear JW, Yasuda H, Hu X, Hieny S, Yuen PS, Hewitt SM, Sher A, Star RA: Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int 2006; 69: 832-836.
14. George P, Bryan MB, Hoang MN, Bamboat ZM, DeMatteo RP: Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J Exp Med 2006; 205: 1277-1283.
15. Yasuda H, Yuen PS, Hu X, Zhou H, Star RA: Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006; 69: 1539-1542.
16. Yasuda H, Leelahavanichkul A, Tsunaoda S, Dear JW, Takahashi Y, Ito S, Hu X, Zhou H, Doi K, Childs R, Klinman DM, Yuen PS, Star RA: Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 2008; 294:F1050-F1058.
17. Ren GL, Bai XF, zhang Y, Chen HM, Huang CX, Wang PZ, Li GY, Zhang Y, Lian JQ: Stable inhibition of hepatitis B virus expression and replication by expressed siRNA. Biochem Biophys Res Commun 2005; 335: 1051-1059.
18. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 2005; 24(suppl 1):52-57.
19. Williams DL, Ha T, Li C, Kalbfleisch JH, Ferguson DA Jr: Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality. Ann Surg 1999; 230: 95-104.
20. Kobayashi N, Matsui Y, Kawase A, Hirata K, Miyagishi M, Taira K, Nishikawa M, Takakura Y: Vector-based in vivo RNA interference: dose-and time-dependent suppression of transgene expression. J Pharmacol Exp Ther 2004; 308: 688-693.
21. Liu F, Song Y, Liu D: Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258-1266.
22. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, Chen J, Shankar P, Lieberman J: RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003; 9: 347-351.
23. Leelahavanichkul A, Yasuda H, Doi K, Hu X, Zhou H, Yuen PS, Star RA: Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. Am J Physiol Renal Physiol 2008; 295:F1825-F1835.
24. Ma Q, Devarajan P: Induction of proapoptotic Daxx following ischemic acute kidney injury. Kidney Int 2008; 74: 310-318.
25. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and cost in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370.
26. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock D: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190-198.
27. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM: TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004; 173: 1179-1183.
28. Brignole C, Marimpietri D, Di Paolo D, Perri P, Morandi F, Pastorino F, Zorzoli A, Pagnan G, Loi M, Caffa I, Erminio G, Haupt R, Gambini C, Pistoia V, Ponzoni M: Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma. Cancer Res 2010; 70: 9816-9826.
29. Fischer SF, Rehm M, Bauer A, Hofling F, Kirschnek S, Rutz M, Bauer S, Wagner H, Hacker G: Toll-like receptor 9 signaling can sensitize fibroblasts for apoptosis. Immunol Lett 2005; 97: 115-122.
30. Ishii KJ, Akira S: Innate immune recognition of, and regulation by, DNA. Trends Immunol 2006; 27: 525-532.
31. Sester DP, Stacey KJ, Sweet MJ, Beasley SJ, Cronau SL, Hume DA: The actions of bacterial DNA on murine macrophages. J Leukoc Biol 1999; 66: 542-548.
32. Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, Mori M, Inayama Y, Yan K, Kobayashi N, Yokota S: Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol Dial Transplant 2010; 25: 2530-2537.
33. Benigni A, Caroli C, Longaretti L, Gagliardini E, Zoja C, Galbusera M, Moioli D, Romagnani P, Tincani A, Andreoli L, Remuzzi G: Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis Rheum 2007; 56: 1569-1578.
34. Sparwasser T, Miethke T, Lipford G, Borschert K, Hacker H, Heeg K, Wagner H: Bacterial DNA causes septic shock. Nature 1997; 386: 336-337.
35. Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K, Wagner H: Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997; 27: 1671-1679.
36. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374: 546-549.
37. Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rudiger M, Boehm O, Fink K, Dreiner U, Grohe C, Hoeft A, Baumgarten G, Koch A, Zacharowski K, Meyer R: Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9. Cardiovasc Res 2008; 78: 26-35.
38. Liu LX, Hu ZJ, Li Y, Su J, Huo Y, Fan LQ: Role of renal cell apoptosis in acute kidney injury induced by sepsis in mice (in Chinese). Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010; 22: 736-739.
39. Lerolle N, Nochy D, Guerot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced renal injury: apotosis and leukocytic infiltration. Intensive Care Med 2010; 36: 471-478.
40. Mariano F, Cantaluppi V, Stella M, Romanazzi GM, Assenzio B, Cairo M, Biancone L, Triolo G, Ranieri VM, Camussi G: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008; 12:R42.
41. Guo R, Wang Y, Minto AW, Quigg RJ, Cunningham PN: Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 2004; 15: 3093-3102.
42. Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, Moore TA, McMilllan TR, Krieg AM, Akira S, Standiford TJ: TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol 2007; 179: 3937-3946.
43. Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S, Henriques-Normark B: Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 2007; 9: 633-644.
44. Minns LA, Menard LC, Foureau DM, Darche S, Ronet C, Mielcarz DW, Buzoni-Gatel D, Kasper LH: TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii . J Immunol 2006; 176: 7589-7597.
45. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115-122.
46. Holly MK, Dear JW, Hu X, Schechter AN, Gladwin MT, Hewitt SM, Yuen PS, Star RA: Biomarker and drug-target discovery using proteomics in a new rat model of sepsis induced acute renal failure. Kidney Int 2006; 70: 496-506.
47. Wan L, Bellomo R, Di Giantomasso D, Ronco C: The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003; 9: 496-502.
48. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J: Antibody mediated in vivo delivery of small interfering RNAs via cell surface receptors. Nat Biotechnol 2005; 23: 709-717.